CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer ’s disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion

Source: Journal of Human Genetics - Category: Genetics & Stem Cells Source Type: research
More News: Alzheimer's | Genetics